Zivo Bioscience Inc (ZIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,485 | 21 | 209 | 1,799 | 3,386 |
| Receivables | 3 | N/A | N/A | N/A | N/A |
| TOTAL | $1,948 | $530 | $928 | $1,902 | $3,729 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 154 | 180 | 200 | 221 | 243 |
| TOTAL | $154 | $180 | $200 | $221 | $243 |
| Total Assets | $2,102 | $710 | $1,128 | $2,123 | $3,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,014 | 2,625 | 1,449 | 731 | 847 |
| Accrued Expenses | 149 | 124 | 99 | 98 | 98 |
| TOTAL | $3,174 | $3,804 | $2,791 | $2,028 | $2,315 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 77 | 267 | 576 | 701 | 773 |
| Other Non-Current Liabilities | 22 | 51 | 79 | 106 | 132 |
| TOTAL | $22 | $51 | $79 | $106 | $132 |
| Total Liabilities | $3,196 | $3,855 | $2,870 | $2,134 | $2,447 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,820 | 1,742 | 1,570 | 1,570 | 1,570 |
| Common Shares | 2 | 9 | 9 | 2 | 9 |
| Retained earnings | -121,673 | -119,848 | -117,778 | -115,805 | -113,164 |
| TOTAL | $-1,094 | $-3,145 | $-1,742 | $-11 | $1,524 |
| Total Liabilities And Equity | $2,102 | $710 | $1,128 | $2,123 | $3,971 |